Utah Equity in Covid Treatment?

Delldude

Sheep Dipped Boy Scout
Gold Supporting Member
Dec 12, 2014
18,226
11,897
1,138
Plasticville U.S.A
Eugene Kontorovich is a professor at George Mason. In Utah, Non-white or Hispanic ethnicity are assessed a higher Covid risk score and are therefore prioritized for monoclonal antibodies.



 
Eugene Kontorovich is a professor at George Mason. In Utah, Non-white or Hispanic ethnicity are assessed a higher Covid risk score and are therefore prioritized for monoclonal antibodies.




Gresham's Law Applied to Language

Misusing equity (in this thread's title) as a synonym for "equality" is spreading like wildfire, as are all creations of the Illiterate Liberal Language Lords. And Conservatives blindly follow their lead. They're not immune to their fraternity brothers' Low-IQ grammar contagion at all.
 
Gresham's Law Applied to Language

Misusing equity (in this thread's title) as a synonym for "equality" is spreading like wildfire, as are all creations of the Illiterate Liberal Language Lords. And Conservatives blindly follow their lead. They're not immune to their fraternity brothers' Low-IQ grammar contagion at all.

Achieving Racial and Ethnic Equity in US Healthcare?


Utah’s Monoclonal Antibody Allocation Guidelines:

Ethical Justification for Using Race/Ethnicity in Patient Selection: COVID-19 has had a
disproportionate impact on low income communities and certain racial/ ethnic minorities in the
United States. Equity calls attention to the systematic differences in health outcomes and
opportunities to be healthy that adversely affect socially discounted and/or marginalized groups.
For COVID-19, these inequities may arise from higher burdens of preexisting comorbid disease,
poor health care access, or not having the option for social distancing due to living in densely
populated neighborhoods or households. There are also more economically disadvantaged
individuals working essential jobs during the pandemic, and many are unable to perform job
functions from the safety of their home. This puts them at greater risk of interacting with others
who may transmit COVID-19. Utah Data from more than one hundred thousand patients with
COVID-19 confirms that even after controlling for age and comorbidities, Utahns who identify from
communities of color have a significantly higher risk of severe disease requiring hospitalization.
Public health interventions may be used to attempt to mitigate these disparities in COVID-19 by
recognizing the structural inequities that underlie them. One way to do this is to include
race/ethnicity in the patient selection criteria. The FDA Emergency Use Authorization for
monoclonal antibodies specifically states that race and ethnicity may be considered when
identifying patients most likely to benefit from this lifesaving treatment.
https://coronavirus-download.utah.gov/Health/Utah_CSC_Monoclonal_Ab_Guidelines_v16_09012021.pdf
 
One might think increasing supply to avoid these issues would be a better solution. Why isn't that a solution?
 
One might think increasing supply to avoid these issues would be a better solution. Why isn't that a solution?

Seeing as making monoclonal antibodies relies on people who have had COVID to give their blood, this is not always possible.
 

Forum List

Back
Top